| 1 |
26752952 | Changes in serum transforming growth factor-β1 levels in chronic hepatitis C patients under antiviral therapy. | 2016 Jan-Mar |
1 |
| 2 |
27215079 | Impact of TGF-β1 Gene Polymorphism (rs1800469) on Treatment Response to Pegylated Interferon/Ribavirin in Iranian Patients with Hepatitis C. | 2016 |
1 |
| 3 |
24496160 | Overexpression of cyclooxygenase-2 and transforming growth factor-beta 1 is an independent predictor of poor virological response to interferon therapy in chronic HCV genotype 4 patients. | 2014 Jan-Feb |
1 |
| 4 |
16699498 | Effects of interferon plus ribavirin treatment on NF-kappaB, TGF-beta1, and metalloproteinase activity in chronic hepatitis C. | 2006 Aug |
1 |
| 5 |
15896245 | TGF-beta1 mRNA expression in liver biopsy specimens and TGF-beta1 serum levels in patients with chronic hepatitis C before and after antiviral therapy. | 2005 Jun |
1 |
| 6 |
16425392 | Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-beta1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C. | 2005 Nov 21 |
1 |
| 7 |
12145664 | Role of cytokines in the assessment of the severity of chronic hepatitis C and the prediction of response to therapy. | 2002 Jun |
2 |